1,254
Participants
Start Date
November 30, 2006
Primary Completion Date
March 31, 2010
Study Completion Date
August 31, 2016
Cediranib
oral tablet
FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)
intravenous infusion
XELOX (Capecitabine and Oxaliplatin)
intravenous oxaliplatin 130 mg/ m\^2(day 1) followed by oral capecitabine 1,000 mg/ m\^2twice daily (day 1 to day 15)
Cediranib Placebo
oral tablet
Research Site, Buenos Aires
Research Site, Capital Federal
Research Site, Ciudad de Buenos Aires
Research Site, Córdoba
Research Site, Resistencia
Research Site, Rosario
Research Site, Santa Fe
Research Site, Ashford
Research Site, Camperdown
Research Site, Heidelberg
Research Site, Hornsby
Research Site, Liverpool
Research Site, Waratah
Research Site, Wodonga
Research Site, Curitiba
Research Site, Goiânia
Research Site, Jaú
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, Salvador
Research Site, Santo André
Research Site, São Paulo
Research Site, Plovdiv
Research Site, Sofia
Research Site, Stara Zagora
Research Site, Varna
Research Site, Veliko Tarnovo
Research Site, Vratsa
Research Site, Beijing
Research Site, Changchun
Research Site, Chengdu
Research Site, Chongqing
Research Site, Fuzhou
Research Site, Guangzhou
Research Site, Hangzhou
Research Site, Nanjing
Research Site, Nanning
Research Site, Shanghai
Research Site, Tianjin
Research Site, Brno
Research Site, Cheb
Research Site, České Budějovice
Research Site, Jičín
Research Site, Jihlava
Research Site, Olomouc
Research Site, Ostrava
Research Site, Prague
Research Site, Pribram - Zdabor
Research Site, Šumperk
Research Site, Zlín
Research Site, Znojmo
Research Site, Essen
Research Site, Freiburg im Breisgau
Research Site, Goslar
Research Site, Hamburg
Research Site, Hildesheim
Research Site, Mannheim
Research Site, Budapest
Research Site, Debrecen
Research Site, Győr
Research Site, Kecskemét
Research Site, Nyíregyháza
Research Site, Szombathely
Research Site, Zalaegerszeg
Research Site, Hyderabad
Research Site, Trivandrum
Research Site, Cebu City
Research Site, Davao City
Research Site, Iloilo City
Research Site, Quezon
Research Site, Quezon City
Research Site, Bydgoszcz
Research Site, Gdansk
Research Site, Gliwice
Research Site, Krakow
Research Site, Olsztyn
Research Site, Torun
Research Site, Wroclaw
Research Site, Goyang-si
Research Site, Seoul
Research Site, Bellinzona
Research Site, Lausanne
Research Site, Locarno
Research Site, Zurich
Research Site, Tainan City
Research Site, Taipei
Research Site, Aberdeen
Research Site, Belfast
Research Site, Leicester
Research Site, Manchester
Lead Sponsor
AstraZeneca
INDUSTRY